These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12553481)

  • 1. Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
    King JR; Nachman S; Yogev R; Hodge J; Aldrovandi G; Damle B; Smith E; Wiznia A; Acosta EP
    Antivir Ther; 2002 Dec; 7(4):267-70. PubMed ID: 12553481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects.
    Damle BD; Kaul S; Behr D; Knupp C
    J Clin Pharmacol; 2002 Jul; 42(7):791-7. PubMed ID: 12092746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.
    Damle B; Ullah I; Doll W; Wiley G; Knupp C
    Br J Clin Pharmacol; 2002 Sep; 54(3):255-61. PubMed ID: 12236845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of didanosine formulations on the pharmacokinetics of amprenavir.
    Shelton MJ; Giovanniello AA; Cloen D; Berenson CS; Keil K; DiFrancesco R; Hewitt RG
    Pharmacotherapy; 2003 Jul; 23(7):835-42. PubMed ID: 12885096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and duration of elevated gastric pH in patients infected with human immunodeficiency virus after administration of chewable, dispersible, buffered didanosine tablets.
    DePestel DD; Kazanjian PH; Cinti SK; Kauffman CA; Carver PL
    Pharmacotherapy; 2004 Nov; 24(11):1539-45. PubMed ID: 15537559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole.
    Damle B; Hess H; Kaul S; Knupp C
    Biopharm Drug Dispos; 2002 Mar; 23(2):59-66. PubMed ID: 11932960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of didanosine in semen of HIV-1-infected men.
    Cruciani M; Liuzzi G; Chirianni A; Audagnotto S; Bonora S; Di Biagio A; Sinicco A; Bassetti M; Gatti G
    J Antimicrob Chemother; 2006 Jun; 57(6):1244-7. PubMed ID: 16556633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatment.
    Hirt D; Bardin C; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Urien S; Foulongne V; Van De Perre P; Tréluyer JM; Msellati P
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4399-406. PubMed ID: 19581461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads.
    Damle BD; Yan JH; Behr D; O'Mara E; Nichola P; Kaul S; Knupp C
    J Clin Pharmacol; 2002 Apr; 42(4):419-27. PubMed ID: 11936567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.
    la Porte C; Verweij-van Wissen C; van Ewijk N; Aarnoutse R; Koopmans P; Reiss P; Stek M; Hekster Y; Burger D
    J Clin Pharmacol; 2005 Feb; 45(2):211-8. PubMed ID: 15647414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Didanosine as a capsule. A reliable drug in a new dosage form].
    Jablonowski H
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():92-5. PubMed ID: 11373794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of spontaneous gastric hypoacidity on the pharmacokinetics of zidovudine and didanosine.
    Shelton MJ; Adams JM; Hewitt RG; Steinwandel C; DeRemer M; Cousins S; Morse GD
    Pharmacotherapy; 1997; 17(3):438-44. PubMed ID: 9165548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of enteric-coated didanosine capsules compared with didanosine tablets in adults with HIV infection.
    Kunches LM; Reinhalter NE; Marquis A; Coakley E; Cohen C; Morris AB; Mazzullo JM
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):150-3. PubMed ID: 11588508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
    Weidle PJ; Abrams EJ; Gvetadze R; Rivadeneira E; Kline MW
    Pediatr Infect Dis J; 2006 Jan; 25(1):59-64. PubMed ID: 16395105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily.
    van der Flier M; Verweel G; van der Knaap LC; van Jaarsveld P; Driessen GJ; van der Lee M; Hartwig NG; Burger DM
    Antivir Ther; 2008; 13(8):1087-90. PubMed ID: 19195335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.
    Morse GD; Fischl MA; Shelton MJ; Cox SR; Driver M; DeRemer M; Freimuth WW
    Antimicrob Agents Chemother; 1997 Jan; 41(1):169-74. PubMed ID: 8980774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability study of two oral formulations of didanosine in healthy volunteers.
    Schramm Andrade S; Kano EK; de Lima Souza Brioschi TM; Koono EE; dos Reis Serra CH; Porta V
    Arzneimittelforschung; 2006; 56(5):359-64. PubMed ID: 16821647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.
    Rongkavilit C; Thaithumyanon P; Chuenyam T; Damle BD; Limpongsanurak S; Boonrod C; Srigritsanapol A; Hassink EA; Hoetelmans RM; Cooper DA; Lange JM; Ruxrungtham K; Phanuphak P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3585-90. PubMed ID: 11709344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.